The Olson group reported that cardiac-specific deletion of PKD1 diminished cardiac hypertrophy and improved cardiac function in response to pressure overload, chronic adrenergic stimuli, or angiotensin II signaling in mice [146]. This evidence concerns the gene PKD1 and cardiac hypertrophy.